128. Yang W, Xia Y, Fang Y, et al. Selective Cell Penetrating Peptide‐Functionalized Polymersomes Mediate Efficient and Targeted Delivery of Methotrexate Disodium to Human Lung Cancer In Vivo. Advanced healthcare materials, 2017.

127. P. Zhong, M. Qiu, J. Zhang, H.L. Sun, R. Cheng*, C. Deng, F.H. Meng, and Z.Y. Zhong*, cRGD-Installed Docetaxel-Loaded Mertansine Prodrug Micelles: Redox-Triggered Ratiometric Dual Drug Release and Targeted Synergistic Treatment of B16F10 Melanoma, Nanotechnology 2017, 28, 295103.127.pdf

126. Y. Fang, W. Yang, L. Cheng, F. Meng, J. Zhang, Z. Zhong, EGFR-targeted multifunctional polymersomal doxorubicin induces selective and potent suppression of orthotopic human liver cancer in vivo, Acta Biomater, 64 (2017) 323-333.126.pdf

125. Z. Zhong, Innovative Polymers for Controlled Release Applications, Biomacromolecules, 18 (2017) 3652-3653.125.pdf

124. W. Yang, Y. Xia, Y. Zou, F. Meng, J. Zhang, Z. Zhong, Bioresponsive Chimaeric Nanopolymersomes Enable Targeted and Efficacious Protein Therapy for Human Lung Cancers in Vivo, Chemistry of Materials, 29 (2017) 8757-8765.124.pdf

123. C. Hang, Y. Zou, Y. Zhong, Z. Zhong, F. Meng, NIR and UV-responsive degradable hyaluronic acid nanogels for CD44-targeted and remotely triggered intracellular doxorubicin delivery, Colloids and Surfaces B: Biointerfaces, 158 (2017) 547-555.123.pdf

122. Y. Zhu, J. Zhang, F. Meng, C. Deng, R. Cheng, J. Feijen, Z. Zhong, cRGD/TAT Dual-Ligand Reversibly Cross-Linked Micelles Loaded with Docetaxel Penetrate Deeply into Tumor Tissue and Show High Antitumor Efficacy in Vivo, ACS Appl Mater Interfaces, 9 (2017) 35651-35663.122.pdf

121. Y. Zou, M. Zheng, W. Yang, F. Meng, K. Miyata, H.J. Kim, K. Kataoka, Z. Zhong, Virus-Mimicking Chimaeric Polymersomes Boost Targeted Cancer siRNA Therapy In Vivo, Advanced Materials, 29 (2017) 1703285.121.pdf

120. M. Qiu, J. Ouyang, H. Sun, F. Meng, R. Cheng, J. Zhang, L. Cheng, Q. Lan, C. Deng, Z. Zhong, Biodegradable Micelles Based on Poly(ethylene glycol)-b-polylipopeptide Copolymer: A Robust and Versatile Nanoplatform for Anticancer Drug Delivery, ACS Appl Mater Interfaces, 9 (2017) 27587-27595.120.pdf

119. N.J.R. Blackburn, B. Vulesevic, B. McNeill, C.E. Cimenci, A. Ahmadi, M. Gonzalez-Gomez, A. Ostojic, Z. Zhong, M. Brownlee, P.J. Beisswenger, R.W. Milne, E.J. Suuronen, Methylglyoxal-derived advanced glycation end products contribute to negative cardiac remodeling and dysfunction post-myocardial infarction, Basic Research in Cardiology, 112 (2017).119.pdf

118. J. Chen, J. Ouyang, Q. Chen, C. Deng, F. Meng, J. Zhang, R. Cheng, Q. Lan, Z. Zhong, EGFR and CD44 Dual-Targeted Multifunctional Hyaluronic Acid Nanogels Boost Protein Delivery to Ovarian and Breast Cancers In Vitro and In Vivo, ACS Appl Mater Interfaces, 9 (2017) 24140-24147.118.pdf

117. J. Qiu, R. Cheng, J. Zhang, H. Sun, C. Deng, F. Meng, Z. Zhong, Glutathione-Sensitive Hyaluronic Acid-Mercaptopurine Prodrug Linked via Carbonyl Vinyl Sulfide: A Robust and CD44-Targeted Nanomedicine for Leukemia, Biomacromolecules, 18 (2017) 3207-3214.117.pdf

116. H. Meng, Y. Zou, P. Zhong, F. Meng, J. Zhang, R. Cheng, Z. Zhong, A Smart Nano-Prodrug Platform with Reactive Drug Loading, Superb Stability, and Fast Responsive Drug Release for Targeted Cancer Therapy, Macromol Biosci, 17 (2017) 1600518.

115. P. Zhong, X. Gu, R. Cheng, C. Deng, F. Meng, Z. Zhong, αvβ3 integrin-targeted micellar mertansine prodrug effectively inhibits triple-negative breast cancer in vivo, Int J Nanomedicine, Volume 12 (2017) 7913-7921.115.pdf

114. Y. Zhu, X. Wang, J. Zhang, F. Meng, C. Deng, R. Cheng, J. Feijen, Z. Zhong, Exogenous vitamin C boosts the antitumor efficacy of paclitaxel containing reduction-sensitive shell-sheddable micelles in vivo, Journal of Controlled Release, 250 (2017) 9-19.114.pdf

113. K. Wu, R. Cheng, J. Zhang, F. Meng, C. Deng, Z. Zhong, Micellar nanoformulation of lipophilized bortezomib: high drug loading, improved tolerability and targeted treatment of triple negative breast cancer, Journal of Materials Chemistry B, 5 (2017) 5658-5667.113.pdf

112. Y. Zhong, F. Meng, C. Deng, X. Mao, Z. Zhong, Targeted inhibition of human hematological cancers in vivo by doxorubicin encapsulated in smart lipoic acid-crosslinked hyaluronic acid nanoparticles, Drug Delivery, 24 (2017) 1482-1490.112.pdf

111. J.T. Wu, J. Zhang, C. Deng*, F.H. Meng, R. Cheng, and Z.Y. Zhong*, Robust, Responsive and Targeted PLGA Anticancer Nanomedicines by Combining Reductively Cleavable Surfactant and Covalent Hyaluronic Acid Coating, ACS Appl. Mater. Interfaces 2017, DOI: 10.1021/acsami.6b15105111.pdf

110. Y. Fang, Y. Jiang, Y. Zou, F.H. Meng*, J. Zhang, C. Deng, H.L. Sun and Z.Y. Zhong*, Targeted glioma chemotherapy by cyclic RGD peptide-functionalized reversibly core-crosslinked multifunctional poly(ethylene glycol)-b-poly(e-caprolactone) micelles, Acta Biomaterialia 2017,http://dx.doi.org/10.1016/j.actbio.2017.01.007110.pdf

109. J.T. Wu, C. Deng*, F.H. Meng, J. Zhang, H.L. Sun, and Z.Y. Zhong*, Hyaluronic acid coated PLGA nanoparticulate docetaxel effectively targets and suppresses orthotopic human lung cancer, J. Control. Release 2017,http://dx.doi.org/10.1016/j.jconrel.2016.12.024109.pdf

108. P. Zhong, H. Meng, J. Qiu, J. Zhang, H.L. Sun, R. Cheng*, and Z.Y. Zhong*,αvβ3 Integrin-Targeted Reduction-Sensitive Micellar Mertansine Prodrug: Superb Drug Loading, Enhanced Stability, and Effective Inhibition of Melanoma Growth In Vivo, J. Control. Release 2017, DOI: 10.1016/j.jconrel.2016.12.011108.pdf

107. Y. Zou, Y.H. Wei, G.L. Wang, F.H. Meng*, M.Y. Gao, G. Storm, and Z.Y. Zhong*, Nano-Polymersomes with an Ultrahigh Iodine Content for High-Performance X-Ray Computed Tomography Imaging In Vivo, Adv. Mater. 2017,http://dx.doi.org/10.1002/adma.201603997107.pdf

106. W. Chen, Y. Zou, Z.Y. Zhong*, and R. Haag *, Cyclo(RGD)-decorated Redox-responsive Nanogels Mediate Targeted Chemotherapy of Integrin Over-expressing Human Glioblastoma In Vivo, Small 2017, DOI: 10.1002/smll.201601997106.pdf

105. N. Zhang, Y.F. Xia, Y. Zou, W.J. Yang, J. Zhang, Z.Y. Zhong*, and F.H. Meng*, ATN-161 Peptide Functionalized Reversibly Crosslinked Polymersomes Mediate Targeted Doxorubicin Delivery into Melanoma-Bearing C57BL/6 Mice, Mol. Pharm. 2017, DOI: 10.1021/acs.molpharmaceut.6b00800105.pdf